Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Rigshospitalet, Department of Hematology Copenhagen, Denmark
  • Amtssygehuset i Herlev Herlev, Denmark
  • GMP Tummes/Weinberg Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
View all 152 locations
View Trial Details
Completed

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

NCT03424122

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Arizona Cancer Center - Out Pt. Tucson, Arizona, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Texas Oncology Austin, Texas, United States
View all 21 locations
View Trial Details
Completed

Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age

NCT03834688

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Carle Cancer Center Urbana, Illinois, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • St. Joseph Mercy Hospital Cancer Care Center Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

NCT02278796

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +13 more
Locations
  • Krankenhaus der Elisabethinen Linz Linz, Austria
  • Hanusch Krankenhaus Wien Vienna, Austria
  • Department for Medical Oncology University Hospital/Inselspital Bern, Switzerland
  • Universitätsspital Zürich Zurich, Switzerland
View Trial Details
Completed

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

NCT01996865

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Local Institution - 055 Tucson, Arizona, United States
  • Local Institution - 077 Little Rock, Arkansas, United States
  • Local Institution - 079 Berkeley, California, United States
  • Local Institution - 142 Concord, California, United States
View all 126 locations
View Trial Details
Completed

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT04477486

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • NHO Nagoya Medical Center /ID# 221958 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 221565 Nagoya, Aichi-ken, Japan
  • Kyushu University Hospital /ID# 223299 Fukuoka, Japan
  • Hokkaido University Hospital /ID# 221662 Sapporo, Hokkaido, Japan
View Trial Details
Completed

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01776840

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tucson, Arizona, United States
  • Burbank, California, United States
  • La Jolla, California, United States
  • Stanford, California, United States
View all 201 locations
View Trial Details

Related conditions